Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Although prospective randomised trials have shown that treating early breast cancer by conservative surgery and radiotherapy is as effective as mastectomy, revelations of scientific misconduct in the largest of these trials last year caused widespread public concern.1 Media reports that one contributor to the United States national surgical adjuvant breast and bowel project had altered some of his data suggested that patients could no longer trust the trial's conclusions, and it left many patients angry and frightened that they had not been treated appropriately. Three articles in last week's New England Journal of Medicine provide reassurance about the efficacy of breast conserving treatment.2 3 4
The first article is an audit of the trial from the United States National Cancer Institute. It reports that 97.5% of the data were entered correctly.2 The second article is a reanalysis of the audited data after 12
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?